A single centre experience of patients with rare cancers referred for early phase clinical trials

A single centre experience of patients with rare cancers referred for early phase clinical trials

Abstract Background Cancers affecting < 6/100,000/year are classified as rare, but they account for up to 25% of all cancers and are associated with worse 5-year survival than common cancers. Early-phase clinical trials (EPCTs) may represent a viable treatment option for patients with rare cancer...

Full description

Saved in:
Bibliographic Details
Main Authors: Angelos Angelakas, Natalie Cook, Donna M. Graham, Matthew Krebs, Fiona Thistlethwaite, Louise Carter
Format: Article
Language:English
Published: BMC 2025-03-01
Series:BMC Cancer
Subjects:
Rare cancers
Early phase trials
Real world data
Prognosis
Precision medicine
Molecular profiling
Online Access:https://doi.org/10.1186/s12885-025-13934-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-13934-2

Similar Items